Koninklijke Philips (PHG) Non-Current Deffered Revenue (2017 - 2026)
Koninklijke Philips' (PHG) quarterly Non-Current Deffered Revenue came in at $512.8 million in Q1 2026, up 18.32% year-on-year from $433.4 million in Q1 2025, and down 3.82% quarter-over-quarter from $533.1 million in Q4 2025.
Koninklijke Philips (PHG) Non-Current Deffered Revenue (2017 - 2026) Analysis & Trends
Koninklijke Philips' Non-Current Deffered Revenue history runs 10 years deep, the most recent figure standing at $512.8 million for Q1 2026.
- On a quarterly basis, Non-Current Deffered Revenue rose 18.32% year-over-year to $512.8 million in Q1 2026; TTM through Mar 2026 was $512.8 million, a 18.32% increase from a year earlier, with the FY2025 full-year figure at $533.1 million, up 15.76% from the prior year.
- Non-Current Deffered Revenue declined to $512.8 million in Q1 2026 per PHG's latest filing, from $533.1 million in the prior quarter.
- Across five years, Non-Current Deffered Revenue topped out at $537.9 million in Q2 2023 and bottomed at $433.4 million in Q1 2025.
- The 5-year median for Non-Current Deffered Revenue is $504.6 million (2023), against an average of $496.6 million.
- Across the five-year window, Non-Current Deffered Revenue declined 10.71% in 2024 and climbed 18.32% in 2026, its largest moves.
- Year by year, Non-Current Deffered Revenue stood at $525.4 million in 2022, then declined by 3.96% to $504.6 million in 2023, then fell by 8.73% to $460.6 million in 2024, then increased by 15.76% to $533.1 million in 2025, then fell by 3.82% to $512.8 million in 2026.
- Per Business Quant, the three latest PHG Non-Current Deffered Revenue figures stand at $512.8 million (Q1 2026), $533.1 million (Q4 2025), and $485.2 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | - |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 512.79 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Steris | 20.59 Bn | 20.16 Bn | 697.10 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 512.79 Mn |
| Dec 31, 2025 | 533.13 Mn |
| Sep 30, 2025 | 485.16 Mn |
| Jun 30, 2025 | 466.37 Mn |
| Mar 31, 2025 | 433.38 Mn |
| Dec 31, 2024 | 460.56 Mn |
| Jun 30, 2024 | 480.29 Mn |
| Dec 31, 2023 | 504.62 Mn |
| Jun 30, 2023 | 537.93 Mn |
| Dec 31, 2022 | 525.43 Mn |
| Jun 30, 2022 | 522.86 Mn |
| Dec 31, 2021 | 510.21 Mn |
| Jun 30, 2021 | 507.00 Mn |
| Dec 31, 2020 | 480.49 Mn |
| Jun 30, 2020 | 395.42 Mn |
| Dec 31, 2019 | 385.20 Mn |
| Jun 30, 2019 | 326.98 Mn |
| Dec 31, 2018 | 257.96 Mn |
| Jun 30, 2018 | 263.75 Mn |
| Dec 31, 2017 | 293.18 Mn |